FOXP3 and graft versus host disease: In human allogeneic HSCT, reduced numbers of CD4+CD25high, CD4+FOXP3+, or CD4+CD25highFOXP3+ cells and reduced FOXP3 mRNA have been observed in the PB of patients with GvHD (133–138).